The RAUORA study is funded by a three year research grant from the Health Research Council of New Zealand.

The trial has been approved by the Southern Health and Disability Ethics Committee. 

Regulatory approval to use Tabex in this trial has been obtained from the New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE).